Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Robust and prolonged gene expression from injectable polymeric implants.

R E Eliaz1, F C Szoka

  • 1Department of Biopharmaceutical Sciences and Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco, CA 94143-0446, USA.

Gene Therapy
|September 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural studies of the monolayers and bilayers formed by a novel cholesterol-phospholipid chimera.

Langmuir : the ACS journal of surfaces and colloids·2011
Same author

Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components.

Gene therapy·2001
Same author

Phage display selection of a peptide DNase II inhibitor that enhances gene delivery.

The journal of gene medicine·2001
Same author

Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG--diortho ester--lipid conjugate.

Bioconjugate chemistry·2001
Same author

Delivery of soluble tumor necrosis factor receptor from in-situ forming PLGA implants: in-vivo.

Pharmaceutical research·2001
Same author

Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.

Cancer research·2001
Same journal

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

Gene therapy·2026
Same journal

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Gene therapy·2026
Same journal

Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

Gene therapy·2026
Same journal

Applications of genome editing technologies in the treatment of human diseases.

Gene therapy·2026
Same journal

High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation.

Gene therapy·2026
Same journal

AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

Gene therapy·2026
See all related articles

This study presents an injectable, biodegradable implant for sustained DNA release over two months, enabling prolonged gene expression. This method supports tissue regeneration and offers a novel approach for gene transfer in vaccination and tissue engineering.

Area of Science:

  • Biomedical Engineering
  • Gene Therapy
  • Regenerative Medicine

Background:

  • Effective gene delivery systems are crucial for sustained therapeutic protein production.
  • Current methods often lack prolonged expression or require complex procedures.
  • The need for localized and sustained delivery of genetic material for tissue regeneration is significant.

Purpose of the Study:

  • To develop and evaluate an injectable, biodegradable DNA-containing implant for sustained gene delivery.
  • To demonstrate prolonged gene expression and therapeutic effects in vivo.
  • To establish a versatile platform for plasmid-based gene transfer applications.

Main Methods:

  • Development of an injectable biodegradable implant encapsulating plasmid DNA.

Related Experiment Videos

  • In vivo implantation and assessment of DNA release kinetics over a 2-month period.
  • Monitoring of gene expression (luciferase), protein secretion (alkaline phosphatase), and angiogenesis (development endothelial locus-1 gene).

    • Main Results:

    • The system achieved sustained DNA release over 2 months, leading to robust and prolonged gene expression.
    • Sustained expression of luciferase and persistent serum levels of secreted alkaline phosphatase were observed.
    • Local delivery of the development endothelial locus-1 gene promoted significant blood vessel formation, indicating successful angiogenesis.

    Conclusions:

    • The injectable biodegradable implant provides a simple and effective method for sustained plasmid DNA delivery.
    • This system facilitates prolonged gene expression and localized therapeutic effects, such as promoting angiogenesis.
    • The technology holds promise as a valuable tool for gene transfer in vaccination and tissue engineering applications.